Accessibility Menu
Catheter Precision logo

Catheter Precision(NYSEMKT) VTAK

Market Cap$3.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-100%
5 Year-100%
1 Year-92%
1 Month-29%
$0.20
+1.40%
+0.00Today
After hours$0.20-$0.00 (-2.46%)
Catheter Precision last closing stock price
MetricPriceDate
Last closeUSD 0.202026-08-28
Catheter Precision stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.11%USD 0.212026-08-21
1 month-29.03%USD 0.282026-07-29
3 month-77.19%USD 0.882026-05-29
Year to date-89.03%USD 1.832025-12-31
1 year-92.22%USD 2.582025-08-28
3 year-99.8%USD 99.242023-08-29
5 year-100%USD 29,830.002021-08-27
Since inception-99.97%USD 598.522023-01-11

Catheter Precision Financials at a Glance

Market Cap

$3.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.92M

Net Income (TTM)

-$13.29M

EPS (TTM)

-$7.34

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$0.20

Volume

467,058.849

Open

$0.20

Previous Close

$0.20

Daily Range

$0.20 - $0.20

52-Week Range

$0.19 - $3.20

Estimated Earnings Date

Nov 12, 2026

VTAK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Catheter Precision

Catheter Precision makes devices that help doctors treat irregular heartbeats. These tools are used by heart specialists to help find heart rhythm problems.

Gadgets That Keep Hearts in Rhythm

  • VIVO System: Non-invasive 3D heart mapping tool for locating irregular heartbeats; main product, but revenue share not specified.
  • LockeT: Suture retention device for wound healing; primary growth driver in 2025, exact revenue share not disclosed.
  • Amigo Remote Catheter System: Robotic arm for controlling heart catheters; not currently marketed, no revenue contribution in 2025.
  • CPNS System: Device in development for treating severe heart failure; not yet approved or generating revenue.
  • PeriKard Kit: Tool for accessing the heart’s outer lining; acquired in 2025, not yet commercialized.

Growth Spurts and New Tricks

  • Launched LockeT in the U.S. in May 2024 and Europe in April 2025.
  • Acquired Cardionomix (CPNS System) and PeriKard (pericardial access kit) in 2025.
  • Formed KardioNav subsidiary in June 2025 for new heart mapping technologies.
  • Expanded international sales, with approximately 18% of Q2 2025 revenue from customers outside the United States.
  • Raised capital through public offerings and private placements in 2024 and 2025.

What Makes Catheter Precision Stand Out

Catheter Precision focuses on minimally invasive heart tools and holds patents in the U.S. and China. Its products are cleared by U.S. and European regulators, supporting global sales. The company uses both direct sales and distributors to reach hospitals and clinics.

Five Things You Need to Know

  • Q2 2025 revenue was $212,000, up 128.0% from Q2 2024.
  • Gross profit in Q2 2025 was $198,000, up 157.1% year-over-year.
  • U.S. sales made up 82% of Q2 2025 revenue; Europe contributed 18%.
  • Net loss for Q2 2025 was $5.1 million, compared to $4.2 million in Q2 2024.
  • Cash and equivalents were $838,000 as of June 30, 2025.

Bottom Line

Catheter Precision has expanded its product line and global reach through acquisitions and new launches. The company remains focused on heart care innovation but faces ongoing financial challenges.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

17

CEO

David A. Jenkins, MBA, CPA

Website

www.catheterprecision.com

Headquarters

Fort Mill, SC 29708, US

VTAK Financials

Key Financial Metrics (TTM)

Gross Margin

47.73%

Operating Margin

-634.99%

Net Income Margin

-693.94%

Return on Equity

-129.76%

Return on Capital

-111.75%

Return on Assets

-36.04%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.97M

Volume

467.06K

Avg. Volume

10.51M

Financials (TTM)

Gross Profit

$914.00K

Operating Income

-$12.16M

EBITDA

-$12.01M

Operating Cash Flow

-$9.31M

Capital Expenditure

-$103.00K

Free Cash Flow

-$9.42M

Cash & ST Invst.

$1.84M

Total Debt

$3.32M

Catheter Precision Performance Analysis

Catheter Precision annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 14,000-36.4%
20232023-12-31USD 442,0003057.1%
20242024-12-31USD 420,000-5.0%
20252025-12-31USD 819,00095.0%
Catheter Precision sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-306.6%
Q42025-12-315.3%
Q12026-03-3181.5%
Q22026-06-30135.9%
Catheter Precision annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -4,936.51-90.8%
20232023-12-31USD -2,467.79-50.0%
20242024-12-31USD -126.92-94.9%
20252025-12-31USD -15.90-87.5%
Catheter Precision sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-347.4%
Q42025-12-31-95.3%
Q12026-03-3158.1%
Q22026-06-3033.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.02M

+380.7%

Gross Profit

$98.00K

-50.5%

Gross Margin

9.62%

N/A

Market Cap

$3.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$223.98K

N/A

Employees

17

N/A

Net Income

-$3.92M

+28.2%

EBITDA

-$3.03M

+47.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.84M

+7.4%

Total Debt

$3.32M

-9.5%

Accounts Receivable

$120.00K

+4.3%

Inventory

$88.00K

+83.3%

Long Term Debt

$1.22M

-10.4%

Short Term Debt

$2.10M

-9.0%

Return on Assets

-36.04%

N/A

Return on Invested Capital

-51.93%

N/A

Free Cash Flow

-$2.89M

-26.8%

Operating Cash Flow

-$2.87M

-26.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GLMDGalmed Pharmaceuticals Ltd.
$4.12-1.20%
UPCUniverse Pharmaceuticals Inc.
$4.58-6.53%
ELABPMGC Holdings Inc.
$5.19-2.26%
WOKWORK Medical Technology Group Ltd. Class A
$2.24-3.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About VTAK

What is the current price of Catheter Precision?

Catheter Precision is trading at $0.20 per share.

What is the 52-week range for Catheter Precision?

Over the past 52 weeks, Catheter Precision has traded between $0.19 and $3.20.

How much debt does Catheter Precision have?

As of the most recent reporting period, Catheter Precision reported total debt of $14.47M.

How much cash does Catheter Precision have on hand?

Catheter Precision reported $643.00K in cash and cash equivalents in its most recent financial results.

What is Catheter Precision’s dividend yield?

Catheter Precision does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services